Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Hold
4,100
﹤0.01% 913
2026
Q1
$1.44M Sell
4,100
-1,700
-29% -$606K ﹤0.01% 810
2025
Q4
$1.9M Hold
5,800
0.01% 737
2025
Q3
$1.64M Hold
5,800
0.01% 754
2025
Q2
$1.62M Buy
5,800
+1,100
+23% +$312K 0.01% 658
2025
Q1
$1.46M Hold
4,700
0.01% 631
2024
Q4
$1.23M Buy
+4,700
New +$1.39M 0.01% 685
2023
Q1
Sell
-800
Closed -$210K 1149
2022
Q4
$210K Buy
+800
New +$214K ﹤0.01% 892

Other funds holding AMGN

Lido Advisors's AMGN Position: Q2 2026 in Review

Lido Advisors reduced its Amgen (AMGN) stake by 0.5% in Q2 2026, selling an estimated $135K and leaving 77,970 shares worth $28.2M. The position accounts for 0.08% of the portfolio, ranked #173.

Lido Advisors first reported a position in AMGN in Q1 2016 and has held it in 41 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Lido Advisors held 77,970 shares of Amgen worth $28.2M as of Q2 2026.
  • Lido Advisors sold 395 Amgen shares in Q2 2026, an estimated $135K.
  • Amgen made up 0.08% of Lido Advisors's portfolio in Q2 2026, its #173 holding.
  • Lido Advisors first reported a position in Amgen in Q1 2016 and has held it in 41 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.